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ABSTRACT 
Background: In 2015, only 42% of Puerto Rican (PR) girls aged 13-17 and 44% of U.S. 
Hispanic girls aged 13-17 were vaccinated with all three Human Papillomavirus (HPV) 
vaccine doses. These percentages were far lower than the Healthy People 2020 goal of 80% of 
girls aged 13-15 completing the vaccine series. The purpose of this study was to examine 
potential differences in HPV awareness and knowledge and HPV vaccine awareness and 
acceptability between a population-based sample of U.S. Hispanic and island Puerto Rican 
women. 
Methods: We restricted our analyses to female respondents from the Health Information 
National Trends Survey (HINTS) 2007 (n=375; U.S. Hispanic) and HINTS Puerto Rico 2009 
(n=417; PR). Using the Wald chi-square test, we assessed if there were significant differences 
in HPV awareness and knowledge and HPV vaccine awareness and acceptability between U.S. 
Hispanic and island PR women. We then utilized logistic or multinomial regression to control 
for covariates on significant outcomes.  
Results: Both groups of Hispanic women were highly knowledgeable that HPV causes cancer 
(89.2% in both samples) and that HPV is a sexually transmitted infection (78.1% [U.S. 
Hispanics] and 84.7% [PR]). Less than 10% of both groups recognized that HPV can clear on 
its own without treatment. Island PR women had significantly higher HPV vaccine awareness 
(66.9% vs.  61.0%; Wald X2 F(1, 97) = 16.03, p < .001) and were more accepting of the HPV 
vaccine for a real or hypothetical daughter, compared to U.S. Hispanic women (74.8% vs. 
56.1%; Wald X2 F(2, 96) = 7.18, p < .001). However, after controlling for sociodemographic 
variables and survey group, there was no longer a difference between the two groups of women 
and HPV vaccine awareness (AOR = .53; 95% CI = .23, 1.24). Moreover, after controlled 
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analysis, island PR women were significantly less likely to have their hypothetical daughter 
get the HPV vaccine, compared to U.S. Hispanic women (AOR = 0.26; 95% CI = .08, .81). 
Conclusions: Future research focused on factors contributing to differences and similarities in 
HPV knowledge and awareness and HPV vaccine awareness and acceptability between these 
two groups of Hispanic women is warranted. Findings may assist in developing health 
education programs and media to promote HPV vaccination among both groups. 
 
Keywords: Human Papillomavirus Vaccination, Hispanic Americans, Puerto Ricans, 
Immunization, Female 
 
INTRODUCTION 
Cancer is the leading cause of death among Hispanics in the United States (U.S.) 
(American Cancer Society, 2012), and the second leading cause of mortality in Puerto Rico (PR) 
(Figueroa-Vallés et al., 2012). Data from the National Cancer Institute (NCI) indicate that U.S. 
Hispanic women have higher 5-year (2009-2013) cervical cancer incidence (9.4 vs. 7.5/100,000) 
and mortality (2.6 vs. 2.3/100,000) rates than non-Hispanic white women (Howlader et al., 2014), 
signifying apparent health disparities between these two population groups. PR Central Cancer 
Registry 2006-2010 data indicate that Puerto Rican women have similar disparities in cervical 
cancer incidence (11.8 vs. 9.9) and mortality (2.6 vs. 2.7) when compared to U.S. Hispanic women 
(Figueroa-Vallés, et al., 2012). Prevention of cervical cancer is possible through the use of three 
vaccines (i.e., Cervarix [bivalent], Gardasil 4 [quadrivalent], and Gardasil 9 [nonavalent]) which 
protect against the oncogenic strains of human papillomavirus (HPV) that cause the majority of all 
HPV-related cancer cases, including cervical cancer (Petrosky, et al., 2015). HPV vaccination is 
recommended for females aged 9-26 and males aged 9-21, though most vaccination efforts 
primarily focus on 11- and 12-year-old adolescents (Petrosky et al., 2015). Currently, the U.S. 
Vaccines for Children (VFC) program (Centers for Disease Control and Prevention, 2012) 
provides vaccination for children who are low-income and uninsured. Provisions of the Affordable 
Care Act (U.S. Department of Health and Human Services, 2014), as well as PR state law (Ortiz 
et al., 2012), also require health insurers to cover the HPV vaccine for girls aged 11–18 years. 
However, despite clinical guidance and widespread availability of the vaccine, not all Hispanic 
girls in the U.S. and PR receive this cancer prevention vaccine. Two-thirds (66%) of U.S. Hispanic 
girls received ≥1 dose of the vaccine in 2015 (Centers for Disease Control and Prevention, 2015a), 
and even fewer received all three doses (44%) (Centers for Disease Control and Prevention, 
2015b). In 2015, only about three out every four (77%) Puerto Rican girls received ≥1 dose of the 
vaccine; fewer completed the HPV vaccine series (42%) (Reagan-Steiner et al., 2015). For both 
groups of females, figures fall short of the Healthy People 2020 target of 80% of girls aged 13-15 
completing the vaccine series (U.S. Department of Health and Human Services, 2010).  
Gaps in the literature include limited assessment of HPV vaccine acceptability and uptake 
(Bair, Mays, Sturm, Perkins, et al., 2008; Constantine & Jerman, 2007; Kepka, Ulrich, & 
Coronado, 2012; Lazcano-Ponce et al., 2001; Watts et al., 2009; Yeganeh, Curtis, & Kuo, 2010) 
among underserved, low income populations such as Hispanics (Fernandez, Allen, Mistry, & 
Kahn, 2010; Kobetz et al., 2010). However, those studies that are available suggest that 
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underserved Hispanic populations have limited and sometimes inaccurate levels of HPV 
knowledge, especially about the virus’ relationship to cervical cancer (Kobetz, et al., 2010; 
Morales-Campos, Markham, Peskin, & Fernandez, 2013; Tiro, Meissner, Kobrin, & Chollette, 
2007; Vanslyke et al., 2008). Health promotion theories (Becker, 1974; Janz & Becker, 1984) 
substantiate that HPV and HPV vaccine knowledge contribute to the adoption and/or maintenance 
of HPV vaccination. In addition, a systematic literature review focusing on barriers to HPV 
vaccination among U.S. adolescents identified a lack of knowledge regarding HPV and HPV 
vaccine as a key barrier for underserved parents (Holman et al., 2014). 
There is also a paucity of research examining differences in HPV knowledge and vaccine 
acceptability regarding adolescents within ethnic groups, such as differences between U.S. 
Hispanics and geographically-isolated island Puerto Rican Hispanics. Researchers have compared 
U.S. Hispanic, non-Hispanic Whites, non-Hispanic blacks, and island Puerto Ricans using 
population-based health data to compare disparities across racial/ethnic groups for breast, stomach, 
liver, cervical, endometrial, colorectal, and oropharyngeal cancers (Ortiz, Perez, et al., 2010; Ortiz, 
Soto-Salgado, Calo, Nogueras, et al., 2010; Ortiz, Soto-Salgado, Calo, Tortolero-Luna, et al., 
2010; Soto-Salgado et al., 2009; Suarez et al., 2009). Investigating if differences exist within the 
Hispanic ethnic group is important because it comprises subgroups (e.g., Mexicans, Puerto Ricans, 
Cubans) that have distinct cultures, immigration histories, healthcare experiences, and 
relationships to the mainland U.S. In addition, researchers have found differences between 
Hispanic subgroups regarding health outcomes such as diabetes prevalence (Arroyo-Johnson et 
al., 2016), AIDS knowledge (Hajat, Lucas, & Kington, 2000), self-assessed health status (Hajat, 
Lucas, & Kington, 2000), and interval since last physician contact (Hajat, Lucas, & Kington, 
2000). Researchers may limit their ability to understand health disparities affecting Hispanics, 
along with their ability to appropriately target intervention efforts, by grouping all subgroups into 
a single Hispanic ethnic category for research purposes. Thus, it remains unclear if current 
explanatory models of HPV knowledge and vaccine acceptability explain behavior among U.S. 
Hispanics and geographically-isolated island Puerto Ricans, two populations disproportionately 
affected by cervical cancer and not meeting current public health HPV vaccination goals.  
The literature also suggests adults (parents) are crucial to the success of HPV vaccine 
uptake efforts because (1) they are the primary decision-makers in their child(ren)’s medical care 
and (2) their beliefs about HPV impact HPV-related health behaviors and outcomes for their 
children. The literature indicates parents are more likely to report willingness to vaccinate if they: 
(1) feel their child is susceptible to HPV or cervical cancer (Dempsey, Zimet, Davis, & Koutsky, 
2006; Fazekas, Brewer, & Smith, 2008; Gerend, Lee, & Shepherd, 2007; Kahn et al., 2009); (2) 
believe the vaccine is effective and provides benefits (Bair et al., 2008; de Visser & McDonnell, 
2008; Dempsey, et al., 2006; Fazekas, et al., 2008; Gerend, et al., 2007; Zimet et al., 2005); and 
(3) perceive few barriers to accessing the vaccine (Fazekas, et al., 2008; Sauvageau, Duval, Gilca, 
Lavoie, & Ouakki, 2007). The literature also provides mixed results (Bair, Mays, Sturm, Perkins, 
et al., 2008; Dempsey, et al., 2006; Fazekas, et al., 2008; Kahn, et al., 2009; Marlow, Waller, & 
Wardle, 2007; Zimet, et al., 2005) regarding perceptions of severity of HPV-related diseases and 
parental attitudes regarding vaccination. Approval from significant others (i.e., spouse, doctor) or 
a parent’s perception that vaccination is the norm are associated with vaccine acceptability 
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(Dempsey, et al., 2006; Dinh et al., 2007; Kahn, et al., 2009; Ogilvie et al., 2007). Mothers’ 
compliance with Pap test screening guidelines has also been positively associated with daughters’ 
HPV vaccine initiation and completion (Chao, Slezak, Coleman, & Jacobsen, 2009; Monnat & 
Wallington, 2013; Rahman, Elam, Balat, & Berenson, 2013). 
Therefore, the purpose of this study was to examine potential differences in HPV 
awareness and knowledge and HPV vaccine awareness and acceptability between a population-
based sample of U.S. Hispanic and island Puerto Rican women. Although cervical cancer or HPV 
risk is not solely determined by knowledge and awareness, these constructs are recognized by 
health promotion theories (Becker, 1974; Janz & Becker, 1984) that substantiate HPV and HPV 
vaccine knowledge contribute to the adoption and/or maintenance of HPV vaccination. In addition, 
the authors of the current paper acknowledge that the U.S. Hispanic and island Puerto Rican 
comparison has certain limitations; however, the authors consider this comparison important in 
order to highlight racial/ethnic group disparities, stimulate hypothesis generation, and illustrate 
use of an innovative, population-based island PR health dataset. 
 
METHODS 
Sample 
The Health Information National Trends Survey (HINTS) was developed by the NCI to 
assess cancer-related behavior (e.g., prevention, screening, and treatment) in the population in 
order to assess associations between key communication constructs and behavioral outcomes, and 
to monitor trends in the rapidly evolving health communication landscape (Tortolero-Luna et al., 
2010). HINTS 2007 used a mixed-mode, dual-frame design for participant recruitment. One frame 
was a list-assisted, random digit dial (RDD) computer-assisted telephone interview, wherein one 
adult from each household was selected for an interview. The second frame was a relatively 
comprehensive national listing of addresses available from the U.S. Postal Service for the purpose 
of administering a mail survey. Both the RDD and mail survey were conducted from January 
through April 2008. The overall response rates were 24.2% for the RDD household screener and 
40.0% for the mailed survey (Cantor et al., 2007; Davis, Dipko, & Sigman, 2009).  
HINTS-PR 2009 used a RDD and a computer-assisted telephone interview system. It used 
a stratified sampling frame representing eight geographic regions designated by the PR 
Department of Health. Within each stratum, sampled telephone numbers were selected with equal 
probability. Non-working and non-residential numbers were eliminated from the sample. Data 
were collected from April to June 2009. Trained bilingual Puerto Rican interviewers collected 639 
interviews from 837 screened households. The unweighted screener and extended interview 
response rate both equaled 76.3%. Further details on the HINTS 2007 and HINTS-PR 2009 
samples and sampling designs are published elsewhere (Cantor, et al., 2007; Davis, et al., 2009).  
For the current study, we restricted our analyses to female respondents in both surveys for 
a total sample of 792 women (n = 375; U.S. Hispanic HINTS 2007 and n = 417; HINTS-PR 2009). 
We selected only adult female respondents for the study because, at the time of survey 
implementation, the focus was on cervical cancer prevention for women and the HPV vaccine was 
only recommended for girls. In addition, some of our outcome variable questions were only asked 
of women. Despite differences in methods of sampling and data collection between the HINTS 
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2007 and HINTS-PR 2009, the overlap in question content provides a point of comparison to 
examine potential variability in HPV awareness and knowledge and HPV vaccine awareness and 
acceptability between U.S. Hispanic and island Puerto Rican women. The ability to compare the 
samples is a strength, not only because island Puerto Ricans are typically not included in U.S. 
public health data (Calo & Ortiz, 2015), but also because detailed data for Hispanic subgroups are 
lacking (Escarce, Morales, & Rumbaut, 2006). Due to the de-identified nature of the publicly-
available HINTS data, the University of Texas Health Science Center at San Antonio Institutional 
Review Board deemed this secondary data analysis exempt from review. 
Measures 
Measures collected included: sociodemographics, Pap test screening history, health status, 
HPV awareness and knowledge, and HPV vaccine awareness and acceptability. Specifically, HPV 
awareness and knowledge, and HPV vaccine awareness and acceptability were used as dependent 
variables, and sociodemographics, Pap test screening history, and health status as covariates. 
Sociodemographic Characteristics. Sociodemographics included: age (18-34 years, 35-49 
years, 50-64 years, 65+ years), health status (excellent/very good, good, fair/poor), health care 
coverage (yes/no), occupational status (employed, unemployed/other, homemaker), marital status 
(married/living as married, separated/divorced/widowed/single, never been married), education 
(high school graduate or less, some college or more), born in U.S. (yes/no), place of birth (PR, 
U.S. mainland, other), number of children under 18 in household (0/1 or more), female children in 
household (yes/no), and annual household income (less than $35,000/$35,000 or more).  
Family history of cancer. Respondents were asked, “Have any of your family members 
ever had cancer?” Response options were: yes, no, and has no family.  
Pap test screening history. Respondents were asked, “When did you have your most recent 
Pap test?” Response options were: a year ago or less, more than 1 but not more than 3 years ago, 
more than 3 but not more than 5 years before, and more than 5 years ago.  
HPV and HPV vaccine awareness. Participants were asked, “Have you ever heard of HPV? 
HPV stands for Human Papillomavirus. It is not HIV, HSV or herpes.” and “Have you heard 
anything about a vaccine or shot to prevent cervical cancer?” Response options for both questions 
were: yes, no, and don’t know. 
HPV knowledge. Only women who responded “yes” to having heard of HPV were asked 
three HPV knowledge questions. The questions assessed whether a woman could correctly identify 
that HPV (1) causes cervical cancer, (2) is transmitted through sexual contact, and (3) may go 
away on its own without treatment. Response options were yes or no. 
HPV vaccine acceptability. A description of the HPV vaccine was read to respondents: “A 
vaccine to prevent the human papillomavirus or HPV infection is recommended for girls ages 11-
12 and is called the cervical cancer vaccine, HPV shot, or GARDASIL®.” To assess vaccine 
acceptability, respondents were asked: “If you had a daughter that age, would you have her get 
it?” Response options were: yes, no, not sure/it depends, and don’t know. 
Analytic Approach  
We used STATA 12.0 for all analyses (StataCorp, 2009). Because of the HINTS sample 
design and weighting procedures, we used the jackknife variance estimation technique. For the 
purposes of these analyses, we coded “don’t know” responses as equivalent to “missing” because 
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of data patterns where some categories had no data, otherwise known as quasi-complete separation, 
causing convergence failures in logistic regression models (Allison, 2008). Missing data were 
excluded from the analyses. We used descriptive statistics (e.g., overall sample size, sample sizes 
in important subgroups, and the proportion of subjects in each of the sociodemographic categories) 
to describe the sample and the distribution of variables. To assess if there were significant 
difference between U.S. Hispanics and island PR women, we conducted the Wald chi-square test. 
We selected the Wald X2 test because (1) all our variables are categorical and our research question 
was to look at difference between two groups (U.S. Hispanic women and island PR women) and 
(2) our dataset is population-based. In addition, for any significant outcomes from the Wald X2 
test, we conducted logistic or multinomial regression to adjust for covariates. Because we 
performed multiple tests on our data, we utilized the modified Bonferroni procedure to control for 
type 1 error (Holland & Copenhaver, 1988). 
 
RESULTS 
Sample Sociodemographics 
Table 1 presents sociodemographic information for both study samples. U.S. Hispanic 
women were commonly between the ages of 35-49 (31.5%), born in the U.S. (53.1%), employed 
(47.7%), married/living as married (56.3%), and in excellent/very good health (36.1%), with a 
high school education or less (53.8%). U.S. Hispanic women also had high rates of health 
insurance coverage (70.8%), were likely to have one or more children in the household (54.7% of 
these, 59.5% had female children), and commonly reported an annual income less than $35,000 
(54.1%). Almost two in five island PR women were aged 65 or older (39.1%) and had a high 
school education or less (51.9%); the majority were born in PR (95.2%). Less than half of island 
PR women were homemakers (43.4%), married/common law (48.0%), and in fair/poor health 
(40.3%). Although four out of five PR women reported an annual income of less than $35,000 
(82.6%), they were well covered by health insurance (96.2%). Approximately one-quarter of these 
women had one or more children in the household (26.4%); of these women, 65.5% had female 
children. The majority of both groups of Hispanic women were up to date on their Pap test 
screening (88.7% and 81.1%, respectively) using current screening guidelines (U.S. Preventive 
Services Task Force, 2012).   
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Table 1. Demographics of U.S. Hispanic women (n=375; HINTS 2007) and island Puerto Rican (PR) women 
(n=417; HINTS-PR 2009), N = 792. 
 U.S. Hispanic  
n (%) 
Island PR 
n (%) 
p-value4  
(Wald X2) 
Pap test screening 
history 
1 year ago or less  230 (66.9)        232 (61.1)        0.58 
More than 1 but not more than 3 years ago 75 (21.8)        76 (20.0)         
More than 3 but not more than 5 years ago 14 (4.1)        29 (7.6)         
More than 5 years ago 24 (7.0) 43 (11.3)  
Family history of 
cancer2 
Yes 216 (58.7)   277 (66.8)   .03 
No  152 (41.3)   138 (33.3)    
Health Status Excellent/Very Good  135 (36.1)     99 (23.7)     .05 
Good 133 (35.6) 150 (36.0)  
Fair/Poor 106 (28.3) 168 (40.3)  
Age2 18-34  112 (29.9)        42 (10.1)        <.001 
35-49 118 (31.5)   81 (19.4)    
50-64  90 (24.0)     128 (30.7)      
+65  55 (14.6)        163 (39.1)         
Health Insurance2 Yes 264 (70.8)   401 (96.2)   <.001 
No  109 (29.2)   16 (3.8)    
Occupational Status2 Employed 178 (47.7) 100 (24.0) <.001 
Unemployed/Other 113 (30.4)  136 (32.6)   
Homemaker 81 (21.7)   181 (43.4)    
Marital Status Married/Living as married  211 (56.3)        200 (48.0)        .14 
Separated/Divorced/Widowed/Single 
(never married) 
164 (43.8)        217 (52.1)         
Education2 High school or less  201 (53.8)       215 (51.9)       .02 
Some college or more 173 (46.2)        200 (48.2)         
Born in U.S.1 Born in U.S. 205 (53.1) 9 (2.2) NA 
Other/Puerto Rico 181 (46.3) 397 (97.8)  
No. of children under 
18 in household2  
0 169 (45.3) 307 (73.6) <.001 
1 or more 204 (54.7) 110 (26.4)  
Female children in 
household3 
Yes 122 (59.5) 72 (65.5) 0.43 
No 83 (40.5) 38 (34.6)  
Annual Income2 Less than $35,000 185 (54.1)        206 (82.6)        <.001 
$35,000 or more  157 (46.0)      43 (17.2)       
Note: 1HINTS 2007 participants were asked, “Were you born in the U.S.?”, with response options Yes or No, 
whereas HINTS-PR 2009 participants were asked, ”Where were you born?”, with response options Puerto Rico, 
continental U.S., or other. 2Variable has missing data. 3n=170 U.S. Hispanic and n=307 island PR skipped this 
question due to HINTS survey skip pattern. 4p-value = significant at .05 level. NA = Not Applicable. 
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Bivariate Analysis 
Table 2 depicts the proportion of the two samples that had ever heard of HPV and the HPV 
vaccine. Both samples had moderately high awareness of HPV (64.0% [U.S. Hispanics] vs. 65.5% 
[PR]). Similarly, both groups of women were highly knowledgeable that HPV causes cancer 
(89.2% in both samples) and that HPV is a sexually transmitted infection (78.1% [U.S. Hispanics] 
and 84.7% [PR]). Less than 10% of both groups recognized that HPV can clear on its own without 
treatment. Island PR women had significantly higher HPV vaccine awareness (66.9% vs. 61.0%; 
Wald X2 F(1, 97) = 16.03, p < .001) and were more accepting of the HPV vaccine for a real or 
hypothetical daughter (74.8% vs. 56.1%; Wald X2 F(2, 96) = 7.18, p < .001), compared to U.S. 
Hispanic women. Of those women who had a female child in the home, 56.3% of U.S. Hispanic 
women indicated acceptance of the HPV vaccine, compared to 76.4 % of island PR women (Wald 
X2 F(2,96) = 3.70, p < .03). For HPV vaccine awareness and acceptability, we conducted additional 
analyses to further explore the significant findings.  
 
Table 2. Differences in HPV awareness, HPV vaccine awareness, HPV knowledge, and HPV vaccine 
acceptability between U.S. Hispanic women (n=375; HINTS 2007) and island Puerto Rican (PR) women 
(n=417; HINTS-PR 2009), N = 792. 
  U.S. 
Hispanic  
n (%) 
Island PR  
n (%) 
p-value3  
(Wald X2) 
HPV Awareness2 Yes  236 (64.0)        271 (65.5)        0.15 
No 133 (36.0)        143 (34.5)         
HPV Vaccine 
Awareness2 
Yes  224 (61.0)        279 (66.9)        <.001 
No* 143 (39.0)        138 (33.1)         
HPV Knowledge1 HPV causes cancer2 
     Yes 
     No  
 
181 (89.2)     
22 (10.8)  
 
189 (89.2)     
23 (10.9)  
0.91 
HPV is transmitted through sexual contact2 
     Yes 
     No 
 
164 (78.1)   
46 (21.9)  
 
183 (84.7)   
33 (15.3)  
.041 
HPV goes away on its own2 
     Yes 
     No 
 
18 (8.3)    
199 (91.7) 
 
14 (5.8)   
227 (94.2)  
0.17 
HPV Vaccine 
Acceptability2 
Yes 205 (56.1)   312 (74.8)   <.001 
No  81 (22.2)   27 (6.5)    
Not Sure 79 (21.6) 68 (16.3)  
Note: 1Participants who answered “No” to the HPV awareness question (n=281) skipped all the subsequent 
HPV knowledge questions due to HINTS survey skip pattern. 2Variable has missing data. 3p-value = significant 
at .05 level. 
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Regression Analysis 
As shown in Table 3, results from the adjusted logistic regression model indicate that after 
controlling for age, health insurance, occupational status, education, number of children in 
household, annual income, family history of cancer, and survey group, there was no longer a 
significant difference between the two groups of Hispanic women and HPV vaccine awareness 
(AOR = .53; 95% CI = .23, 1.24; p = .14). Women having at least some college education were 
also 52% less likely to report being aware of the HPV vaccine, compared to women having a high 
school education or less (AOR = .48; 95% CI = .25, .91; p = .03).   
 
Table 3. Crude and adjusted odds ratio assessing association between demographic 
characteristics and HPV vaccine awareness using logistic regression 
  HPV Vaccine Awareness (N = 570) 
Characteristic 
Crude 
OR 95% CI P2 
Adj. 
OR 95% CI P2 
Age1                 
18-34  1.00 REF REF  1.00 REF REF  
35-49 1.08 0.50 2.31 0.84 1.32 0.54 3.23 0.54 
50-64  0.88 0.43 1.78 0.72 0.96 0.40 2.29 0.93 
65+ 2.01 0.90 3.88 0.06 2.40 0.72 7.94 0.15 
Health Insurance1         
Yes 1.00 REF REF  1.00 REF REF  
No 3.01 1.57 5.78 0.00 2.27 0.98 5.26 0.06 
Occupation Status1         
Employed  1.00 REF REF  1.00 REF REF  
Unemployed/ 
Other 2.80 1.45 5.40 0.00 2.04 0.85 4.92 0.11 
Homemaker 1.57 0.86 2.85 0.14 1.27 0.57 2.85 0.56 
Education1         
≥High school  1.00 REF REF  1.00 REF REF  
<High school  0.24 0.14 0.42 0.00 0.48 0.25 0.91 0.03 
No. children in 
household1         
0 1.00 REF REF  1.00 REF REF  
1 or more 1.41 0.76 2.61 0.27 1.46 0.64 3.36 0.37 
Annual Income1         
Less than $35,000 1.00 REF REF  1.00 REF REF  
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$35,000 or more 0.37 0.16 0.83 0.02 0.46 0.19 1.13 0.09 
Family history of 
cancer1         
Yes 1.00 REF REF  1.00 REF REF  
No  0.59 0.30 1.16 0.12 0.72 0.29 1.75 0.46 
Group         
U.S. Hispanic 
Women 1.00 REF REF  1.00 REF REF  
Island PR Women 0.45 0.30 0.67 0.00 0.53 0.23 1.24 0.14 
Note: 1Variable has missing data. 2p-value = significant at .05 level. 
 
Regarding HPV vaccine acceptability, results from the adjusted multinomial regression 
model comparing revealed that island PR women were significantly less likely to have their 
hypothetical daughter get the HPV vaccine, compared to US Hispanic women (AOR = 0.26; 95% 
CI = .08, .81; p=.02). Within the total sample, none of the sociodemographic variables were 
statistically associated with HPV vaccine acceptability (Table 4).  
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Table 4. Crude and adjusted odds ratio comparing HPV vaccine acceptability (yes, no, not sure) by demographic characteristics using multinomial logistic regression (N = 
567) 
  HPV Vaccine Acceptability - Yes  HPV Vaccine Acceptability - No  HPV Vaccine Acceptability - Not Sure  
 
Crude 
OR 95% CI 
Adj. 
OR 95% CI 
Crude 
OR 95% CI P2 
Adj. 
OR 95% CI P2 
Crude 
OR 95% CI P2 
Adj. 
OR 95% CI P2 
Age1       
  
    
  
          
  
              
  
      
18-34  1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
35-49 1.00 REF REF 1.00 REF REF 2.00 0.75 5.32 0.16 2.70 0.96 7.60 0.06 1.00 0.36 2.79 1.00 1.48 0.47 4.69 0.50 
50-64  1.00 REF REF 1.00 REF REF 1.84 0.74 4.55 0.19 2.85 0.91 8.95 0.07 1.47 0.62 3.45 0.38 1.81 0.66 4.97 0.25 
65+ 1.00 REF REF 1.00 REF REF 2.44 0.87 6.82 0.09 2.96 0.71 12.4 0.14 1.70 0.49 5.88 0.40 0.95 0.15 5.79 0.95 
Health 
Insurance1    
 
  
 
                 
Yes 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
No 1.00 REF REF 1.00 REF REF 1.29 0.53 3.13 0.57 1.20 0.48 2.97 0.69 1.13 0.43 2.96 0.81 1.17 0.38 3.57 0.78 
Occupatio
n Status1    
 
  
 
                 
Employed  1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
Unemploy
ed/ 
Other 1.00 REF REF 1.00 REF REF 1.85 0.82 4.17 0.14 2.41 0.98 5.96 0.06 1.68 0.67 4.20 0.27 1.86 0.63 5.47 0.26 
Homemak
er 1.00 REF REF 1.00 REF REF 1.15 0.51 2.56 0.73 0.93 0.35 2.48 0.88 0.79 0.48 1.31 0.36 0.69 0.34 1.38 0.29 
Education
1    
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≥HS 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
<HS 1.00 REF REF 1.00 REF REF 0.67 0.34 1.31 0.24 0.77 0.34 1.72 0.52 0.86 0.44 1.67 0.65 1.20 0.50 2.87 0.68 
# children 
in HH1    
 
  
 
                 
0 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
1 or more 1.00 REF REF 1.00 REF REF 1.02 0.47 2.21 0.95 1.17 0.53 2.59 0.70 1.10 0.53 2.26 0.80 1.17 0.43 3.18 0.75 
Annual 
Income1    
 
  
 
                 
>$35,000 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
$35,000+ 1.00 REF REF 1.00 REF REF 1.62 0.79 3.32 0.19 1.95 0.83 4.57 0.12 0.66 0.33 1.34 0.25 0.66 0.33 1.33 0.24 
Family 
cancer 
HX1    
 
  
 
                 
Yes 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
No  1.00 REF REF 1.00 REF REF 0.65 0.29 1.43 0.28 0.53 0.24 1.15 0.11 1.01 0.51 2.02 0.97 0.77 0.30 1.98 0.59 
Survey 
Group    
 
  
 
                 
U.S. 
Hispanic 
WM 1.00 REF REF 1.00 REF REF 1.00 REF REF  1.00 REF REF  1.00 REF REF  1.00 REF REF  
Island PR 
WM 1.00 REF REF 
 
1.00 REF REF 0.30 0.13 0.68 0.00 0.26 0.08 0.81 0.02 0.60 0.32 1.12 0.11 0.73 0.31 1.70 0.47 
Note: The 2 categories "no" and "unsure" are compared with the omitted reference category of "yes"; 1Variable is missing data. 2p-value = significant at .05 level. 
HH = household, WM =  women, HS = high school, HX = history 
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DISCUSSION 
To our knowledge, this is the first study to examine potential differences in HPV awareness 
and knowledge and HPV vaccine awareness and acceptability between a population-based sample 
of U.S. Hispanic and island PR women. The majority of U.S. Hispanic women and island PR 
women in this study reported high levels of HPV awareness. Some studies have reported similar 
results (Allen et al., 2010; Kepka, et al., 2012; Morales-Campos, et al., 2013), while others have 
reported low levels of HPV awareness among Hispanics (Bair, Mays, Sturm, & Zimet, 2008; 
Vanslyke, et al., 2008). This inconsistency may be attributed to some of the studies having been 
conducted prior to the HPV vaccine’s licensure and prior to media advertising campaigns bringing 
attention to HPV and preventive vaccination. Among the women who had heard of HPV in our 
study, knowledge levels were high. The majority of women in both Hispanic samples correctly 
identified that HPV causes cancer, is transmitted through sexual contact, and can clear on its own. 
Kobetz et al. (2010) reported similar findings among U.S. Hispanic women, while other studies of 
Hispanic women reported low levels of HPV knowledge (Kepka, et al., 2012; Vanslyke, et al., 
2008). Fernandez et al.’s (2014) study of PR women also found low levels of HPV and cervical 
cancer knowledge. These inconsistencies in both U.S. Hispanic and PR samples could be due to 
variations in how researchers measured HPV knowledge and in the different samples of Hispanic 
women who participated in these studies. 
In bivariate analyses, our study found that island PR women were more aware of and 
accepting of the HPV vaccine when compared to U.S. Hispanic women, but the literature shows 
inconsistencies. Colon-Lopez et al. (2015) found similar findings in their sample of parents 
attending a federally qualified health center in PR. In that particular study, over half of the parents 
had heard of the HPV vaccine and more than three-quarters were willing to get their child 
vaccinated. Conversely, Fernandez et al. (2014), in their study of mothers and daughters living in 
PR, found that there was low knowledge of HPV vaccination; mothers also reported reluctance to 
vaccinate their daughters due to concerns about vaccine efficacy and benefits of HPV vaccination. 
Our findings could also be attributed to when the data (2008 vs. 2009) for each sample were 
collected. In 2008, the HPV vaccine had only been licensed for use for two years, compared to 
three years with the PR sample. Thus, the island PR survey respondents may have received more 
exposure to HPV vaccine media advertising and/or recommendations from health care providers. 
Interestingly, when controlling for significant sociodemographics and survey group, significant 
differences in HPV vaccine awareness and acceptability were no longer present between the two 
groups of women. This shift illustrates the important influence of social determinants of health 
(e.g., education), on awareness of and action on preventive health measures. 
Limitations 
The limitations of this study include its cross-sectional study design, overall low survey 
response rate, differing years of data collection, and small sample size for both U.S. Hispanic 
(HINTS 2007; n = 375) and island PR (HINTS-PR 2009; n = 417) women. The current study 
provides a snapshot of U.S. Hispanic and island PR women at one point in time; thus, we are 
unable to draw any conclusions about causal relationships between awareness, knowledge, and 
vaccine acceptability. HINTS 2007 response rates were low, which could raise issues regarding 
selection bias for those who did versus did not respond, especially in underserved populations. 
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HINTS 2007 and HINTS-PR 2009 data were collected seven to ten years ago; given the time that 
has passed, the HPV vaccination environment has changed over the years, potentially altering the 
methods of information dissemination. The HINTS 2007 survey also did not collect information 
from respondents regarding country of origin; thus, we were unable to differentiate the sample into 
cultural groups (e.g., Mexican, Cuban, Puerto Rican). We acknowledge that although island PR 
are a Hispanic subgroup, U.S. Hispanics comprise individuals from different Hispanic subgroup 
origins, each of which may have variable beliefs, attitudes, knowledge, and cervical cancer 
incidence and mortality rates (Pinheiro et al., 2009). Although comparing U.S. Hispanics to island 
PR is not a perfect comparison, racial/ethnic groups may identify differences in personal 
determinants of health that could potentially impact HPV-related cancer prevention efforts in 
vulnerable populations and generate hypotheses about how these determinants and other 
environmental factors impact uptake of the HPV vaccine. The findings provide evidence that 
similarities and differences in HPV knowledge and awareness and HPV vaccine awareness and 
acceptability do exist between ethnic subgroups that otherwise are routinely excluded from or 
grouped together in public health research. Furthermore, this current analysis extends the original 
intent of HINTS-PR, which was to use the collected data for secondary data analyses, including 
regional geographic comparisons within PR and comparison of differences between HINTS-PR 
and mainland HINTS results, and to inform cancer control research and practice for Hispanic 
populations (Tortolero-Luna et al., 2010). 
 
CONCLUSION 
Given that both U.S. Hispanic and island PR women have higher cervical cancer incidence 
and mortality rates than non-Hispanic white women, our findings provide novel insight into 
similarities and differences between groups regarding HPV awareness and knowledge and HPV 
vaccine awareness acceptance that may assist in developing culturally appropriate health 
promotion programs to improve HPV vaccination rates among both groups. Future research should 
further explore these in-group differences, especially reasons why island PR women may be more 
accepting of the HPV vaccine overall, but also why differences may exist within specific PR 
sociodemographic groups. Further qualitative and quantitative assessments of what in the PR 
socio-cultural context or environment influences acceptance (or non-acceptance) of the HPV 
vaccine may contribute to the current body of evidence and aid in the development of effective 
health education programs. 
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